Do analysts recommend SKIN or USNA?

Beauty Health currently has a consensus target price of $1.38, indicating a potential upside of 134.64%. Given Beauty Health's stronger consensus rating and higher possible upside, equities analysts clearly believe Beauty Health is more favorable than USANA Health Sciences. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Beauty Health 1 Sell rating(s) 5 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 USANA Health Sciences 2 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media refer more to SKIN or USNA?

In the previous week, Beauty Health had 7 more articles in the media than USANA Health Sciences. MarketBeat recorded 9 mentions for Beauty Health and 2 mentions for USANA Health Sciences. Beauty Health's average media sentiment score of 0.81 beat USANA Health Sciences' score of 0.05 indicating that Beauty Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Beauty Health 4 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive USANA Health Sciences 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate YSG or SKIN?

Beauty Health has a consensus price target of $1.38, indicating a potential upside of 134.64%. Given Beauty Health's stronger consensus rating and higher possible upside, analysts plainly believe Beauty Health is more favorable than Yatsen. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Yatsen 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Beauty Health 1 Sell rating(s) 5 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Is YSG or SKIN more profitable?

Yatsen has a net margin of -4.63% compared to Beauty Health's net margin of -9.79%. Yatsen's return on equity of -7.26% beat Beauty Health's return on equity. Company Net Margins Return on Equity Return on Assets Yatsen -4.63% -7.26% -5.42% Beauty Health -9.79% -47.83% -5.79%

Do analysts prefer SKIN or NUS?

Beauty Health presently has a consensus price target of $1.38, suggesting a potential upside of 134.64%. Given Beauty Health's stronger consensus rating and higher possible upside, equities research analysts clearly believe Beauty Health is more favorable than Nu Skin Enterprises. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Beauty Health 1 Sell rating(s) 5 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Nu Skin Enterprises 2 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media refer more to SKIN or NATR?

In the previous week, Beauty Health had 6 more articles in the media than Nature's Sunshine Products. MarketBeat recorded 9 mentions for Beauty Health and 3 mentions for Nature's Sunshine Products. Nature's Sunshine Products' average media sentiment score of 1.43 beat Beauty Health's score of 0.81 indicating that Nature's Sunshine Products is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Beauty Health 4 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Nature's Sunshine Products 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor SKIN or NAGE?

In the previous week, Beauty Health had 3 more articles in the media than Niagen Bioscience. MarketBeat recorded 9 mentions for Beauty Health and 6 mentions for Niagen Bioscience. Beauty Health's average media sentiment score of 0.81 beat Niagen Bioscience's score of 0.13 indicating that Beauty Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Beauty Health 4 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Niagen Bioscience 0 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Beauty Health (SKIN) Competitors

$0.59 +0.00 (+0.67%)

Closing price 04:00 PM Eastern

Extended Trading

$0.60 +0.01 (+0.86%)

As of 07:07 PM Eastern

Compare

SKIN vs. USNA, YSG, NUS, NATR, and NAGE

Should you buy Beauty Health stock or one of its competitors? Beauty Health's main competitors and comparable companies include USANA Health Sciences (USNA), Yatsen (YSG), Nu Skin Enterprises (NUS), Nature's Sunshine Products (NATR), and Niagen Bioscience (NAGE). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "personal care products" industry.

How does Beauty Health compare to USANA Health Sciences?

Beauty Health (NASDAQ:SKIN) and USANA Health Sciences (NYSE:USNA) are both small-cap consumer staples companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, dividends, earnings, institutional ownership, risk, profitability, valuation and analyst recommendations.

Beauty Health has a beta of 1.05, meaning that its share price is 5% more volatile than the broader market. Comparatively, USANA Health Sciences has a beta of 0.68, meaning that its share price is 32% less volatile than the broader market.

USANA Health Sciences has a net margin of -2.43% compared to Beauty Health's net margin of -9.79%. USANA Health Sciences' return on equity of 3.41% beat Beauty Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Beauty Health	-9.79%	-47.83%	-5.79%
USANA Health Sciences	-2.43%	3.41%	2.50%

93.3% of Beauty Health shares are owned by institutional investors. Comparatively, 54.3% of USANA Health Sciences shares are owned by institutional investors. 35.5% of Beauty Health shares are owned by company insiders. Comparatively, 0.8% of USANA Health Sciences shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

USANA Health Sciences has higher revenue and earnings than Beauty Health. USANA Health Sciences is trading at a lower price-to-earnings ratio than Beauty Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Beauty Health	$300.80M	0.25	-$9.52M	-$0.22	N/A
USANA Health Sciences	$925.26M	0.30	$10.76M	-$1.21	N/A

Beauty Health currently has a consensus target price of $1.38, indicating a potential upside of 134.64%. Given Beauty Health's stronger consensus rating and higher possible upside, equities analysts clearly believe Beauty Health is more favorable than USANA Health Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Beauty Health	1 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
USANA Health Sciences	2 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Beauty Health had 7 more articles in the media than USANA Health Sciences. MarketBeat recorded 9 mentions for Beauty Health and 2 mentions for USANA Health Sciences. Beauty Health's average media sentiment score of 0.81 beat USANA Health Sciences' score of 0.05 indicating that Beauty Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Beauty Health	4 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
USANA Health Sciences	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Beauty Health beats USANA Health Sciences on 10 of the 16 factors compared between the two stocks.

How does Beauty Health compare to Yatsen?

Yatsen (NYSE:YSG) and Beauty Health (NASDAQ:SKIN) are both small-cap consumer staples companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, valuation, analyst recommendations, media sentiment, risk, profitability, institutional ownership and earnings.

Beauty Health has lower revenue, but higher earnings than Yatsen. Yatsen is trading at a lower price-to-earnings ratio than Beauty Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Yatsen	$614.62M	0.39	-$11.56M	-$0.32	N/A
Beauty Health	$300.80M	0.25	-$9.52M	-$0.22	N/A

Yatsen has a net margin of -4.63% compared to Beauty Health's net margin of -9.79%. Yatsen's return on equity of -7.26% beat Beauty Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Yatsen	-4.63%	-7.26%	-5.42%
Beauty Health	-9.79%	-47.83%	-5.79%

Beauty Health has a consensus price target of $1.38, indicating a potential upside of 134.64%. Given Beauty Health's stronger consensus rating and higher possible upside, analysts plainly believe Beauty Health is more favorable than Yatsen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Yatsen	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Beauty Health	1 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

93.3% of Beauty Health shares are owned by institutional investors. 29.0% of Yatsen shares are owned by insiders. Comparatively, 35.5% of Beauty Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Yatsen has a beta of -1.71, meaning that its share price is 271% less volatile than the broader market. Comparatively, Beauty Health has a beta of 1.05, meaning that its share price is 5% more volatile than the broader market.

In the previous week, Beauty Health had 9 more articles in the media than Yatsen. MarketBeat recorded 9 mentions for Beauty Health and 0 mentions for Yatsen. Beauty Health's average media sentiment score of 0.81 beat Yatsen's score of 0.00 indicating that Beauty Health is being referred to more favorably in the news media.

Company	Overall Sentiment
Yatsen	Neutral
Beauty Health	Positive

Summary

Beauty Health beats Yatsen on 11 of the 16 factors compared between the two stocks.

How does Beauty Health compare to Nu Skin Enterprises?

Beauty Health (NASDAQ:SKIN) and Nu Skin Enterprises (NYSE:NUS) are both small-cap consumer staples companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, dividends, media sentiment, analyst recommendations, institutional ownership, earnings, risk and profitability.

Nu Skin Enterprises has higher revenue and earnings than Beauty Health. Beauty Health is trading at a lower price-to-earnings ratio than Nu Skin Enterprises, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Beauty Health	$300.80M	0.25	-$9.52M	-$0.22	N/A
Nu Skin Enterprises	$1.49B	0.16	$160.20M	-$4.47	N/A

In the previous week, Beauty Health had 9 more articles in the media than Nu Skin Enterprises. MarketBeat recorded 9 mentions for Beauty Health and 0 mentions for Nu Skin Enterprises. Beauty Health's average media sentiment score of 0.81 beat Nu Skin Enterprises' score of 0.38 indicating that Beauty Health is being referred to more favorably in the media.

Company	Overall Sentiment
Beauty Health	Positive
Nu Skin Enterprises	Neutral

Beauty Health has a beta of 1.05, suggesting that its share price is 5% more volatile than the broader market. Comparatively, Nu Skin Enterprises has a beta of 0.91, suggesting that its share price is 9% less volatile than the broader market.

Beauty Health has a net margin of -9.79% compared to Nu Skin Enterprises' net margin of -15.73%. Nu Skin Enterprises' return on equity of 6.58% beat Beauty Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Beauty Health	-9.79%	-47.83%	-5.79%
Nu Skin Enterprises	-15.73%	6.58%	3.63%

93.3% of Beauty Health shares are owned by institutional investors. Comparatively, 82.8% of Nu Skin Enterprises shares are owned by institutional investors. 35.5% of Beauty Health shares are owned by insiders. Comparatively, 2.8% of Nu Skin Enterprises shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Beauty Health presently has a consensus price target of $1.38, suggesting a potential upside of 134.64%. Given Beauty Health's stronger consensus rating and higher possible upside, equities research analysts clearly believe Beauty Health is more favorable than Nu Skin Enterprises.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Beauty Health	1 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Nu Skin Enterprises	2 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Beauty Health beats Nu Skin Enterprises on 11 of the 16 factors compared between the two stocks.

How does Beauty Health compare to Nature's Sunshine Products?

Beauty Health (NASDAQ:SKIN) and Nature's Sunshine Products (NASDAQ:NATR) are both small-cap consumer staples companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, institutional ownership, valuation, media sentiment, analyst recommendations, risk, profitability and earnings.

93.3% of Beauty Health shares are owned by institutional investors. Comparatively, 79.4% of Nature's Sunshine Products shares are owned by institutional investors. 35.5% of Beauty Health shares are owned by insiders. Comparatively, 3.1% of Nature's Sunshine Products shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Beauty Health has a beta of 1.05, indicating that its stock price is 5% more volatile than the broader market. Comparatively, Nature's Sunshine Products has a beta of 0.81, indicating that its stock price is 19% less volatile than the broader market.

In the previous week, Beauty Health had 6 more articles in the media than Nature's Sunshine Products. MarketBeat recorded 9 mentions for Beauty Health and 3 mentions for Nature's Sunshine Products. Nature's Sunshine Products' average media sentiment score of 1.43 beat Beauty Health's score of 0.81 indicating that Nature's Sunshine Products is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Beauty Health	4 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Nature's Sunshine Products	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Beauty Health currently has a consensus target price of $1.38, indicating a potential upside of 134.64%. Nature's Sunshine Products has a consensus target price of $30.50, indicating a potential upside of 143.22%. Given Nature's Sunshine Products' stronger consensus rating and higher possible upside, analysts plainly believe Nature's Sunshine Products is more favorable than Beauty Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Beauty Health	1 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Nature's Sunshine Products	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67

Nature's Sunshine Products has a net margin of 3.68% compared to Beauty Health's net margin of -9.79%. Nature's Sunshine Products' return on equity of 12.88% beat Beauty Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Beauty Health	-9.79%	-47.83%	-5.79%
Nature's Sunshine Products	3.68%	12.88%	8.17%

Nature's Sunshine Products has higher revenue and earnings than Beauty Health. Beauty Health is trading at a lower price-to-earnings ratio than Nature's Sunshine Products, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Beauty Health	$300.80M	0.25	-$9.52M	-$0.22	N/A
Nature's Sunshine Products	$480.14M	0.46	$19.52M	$1.01	12.42

Summary

Nature's Sunshine Products beats Beauty Health on 12 of the 16 factors compared between the two stocks.

How does Beauty Health compare to Niagen Bioscience?

Beauty Health (NASDAQ:SKIN) and Niagen Bioscience (NASDAQ:NAGE) are both small-cap consumer staples companies, but which is the better stock? We will compare the two companies based on the strength of their risk, valuation, dividends, analyst recommendations, profitability, media sentiment, institutional ownership and earnings.

Niagen Bioscience has lower revenue, but higher earnings than Beauty Health. Beauty Health is trading at a lower price-to-earnings ratio than Niagen Bioscience, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Beauty Health	$300.80M	0.25	-$9.52M	-$0.22	N/A
Niagen Bioscience	$129.42M	1.66	$17.38M	$0.18	14.94

Beauty Health has a beta of 1.05, meaning that its share price is 5% more volatile than the broader market. Comparatively, Niagen Bioscience has a beta of 2.02, meaning that its share price is 102% more volatile than the broader market.

93.3% of Beauty Health shares are owned by institutional investors. Comparatively, 15.4% of Niagen Bioscience shares are owned by institutional investors. 35.5% of Beauty Health shares are owned by insiders. Comparatively, 10.0% of Niagen Bioscience shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Beauty Health currently has a consensus price target of $1.38, indicating a potential upside of 134.64%. Niagen Bioscience has a consensus price target of $10.33, indicating a potential upside of 284.14%. Given Niagen Bioscience's stronger consensus rating and higher possible upside, analysts clearly believe Niagen Bioscience is more favorable than Beauty Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Beauty Health	1 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Niagen Bioscience	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	3.00

In the previous week, Beauty Health had 3 more articles in the media than Niagen Bioscience. MarketBeat recorded 9 mentions for Beauty Health and 6 mentions for Niagen Bioscience. Beauty Health's average media sentiment score of 0.81 beat Niagen Bioscience's score of 0.13 indicating that Beauty Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Beauty Health	4 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Niagen Bioscience	0 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Niagen Bioscience has a net margin of 12.39% compared to Beauty Health's net margin of -9.79%. Niagen Bioscience's return on equity of 17.95% beat Beauty Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Beauty Health	-9.79%	-47.83%	-5.79%
Niagen Bioscience	12.39%	17.95%	13.17%

Summary

Niagen Bioscience beats Beauty Health on 12 of the 17 factors compared between the two stocks.

Get Beauty Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SKIN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SKIN vs. The Competition

Export

Metric	Beauty Health	Personal Care Products Industry	Consumer Staples Sector	NASDAQ Exchange
Market Cap	$76.26M	$22.70B	$15.49B	$13.44B
Dividend Yield	N/A	5.39%	3.32%	16.47%
P/E Ratio	-2.68	21.08	13.73	26.10
Price / Sales	0.26	12.68	262,948.44	87.31
Price / Cash	3.84	26.24	57.01	52.81
Price / Book	1.23	2.82	4.28	6.27
Net Income	-$9.52M	$1.13B	$839.81M	$382.03M
7 Day Performance	-6.37%	-1.16%	-0.46%	-0.89%
1 Month Performance	-13.88%	-7.79%	-4.70%	-5.32%
1 Year Performance	-64.25%	-23.13%	8.02%	0.76%

Beauty Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SKIN Beauty Health	2.3654 of 5 stars	$0.59 +0.7%	$1.38 +133.1%	-64.9%	$76.26M	$300.80M	N/A	613
USNA USANA Health Sciences	1.519 of 5 stars	$14.75 +2.7%	N/A	-44.0%	$272.21M	$925.26M	N/A	1,570	News Coverage Analyst Upgrade
YSG Yatsen	0.3727 of 5 stars	$2.65 -2.9%	N/A	-68.8%	$248.57M	$614.62M	N/A	1,623
NUS Nu Skin Enterprises	1.4282 of 5 stars	$4.65 +2.1%	N/A	-58.6%	$226.12M	$1.49B	N/A	2,800
NATR Nature's Sunshine Products	4.1918 of 5 stars	$12.43 -1.3%	$30.50 +145.5%	-17.5%	$218.68M	$480.14M	12.30	806	News Coverage Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SKIN) was last updated on 10/7/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Beauty Health (SKIN) Competitors

SKIN vs. USNA, YSG, NUS, NATR, and NAGE

How does Beauty Health compare to USANA Health Sciences?

Summary

How does Beauty Health compare to Yatsen?

Summary

How does Beauty Health compare to Nu Skin Enterprises?

Summary

How does Beauty Health compare to Nature's Sunshine Products?

Summary

How does Beauty Health compare to Niagen Bioscience?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SKIN vs. The Competition

Beauty Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Beauty Health (SKIN) Competitors

SKIN vs. USNA, YSG, NUS, NATR, and NAGE

How does Beauty Health compare to USANA Health Sciences?

Which has more volatility & risk, SKIN or USNA?

Is SKIN or USNA more profitable?

Do institutionals and insiders believe in SKIN or USNA?

Which has higher earnings & valuation, SKIN or USNA?

Do analysts recommend SKIN or USNA?

Does the media refer more to SKIN or USNA?

Summary

How does Beauty Health compare to Yatsen?

Which has better earnings and valuation, YSG or SKIN?

Is YSG or SKIN more profitable?

Do analysts rate YSG or SKIN?

Do institutionals & insiders hold more shares of YSG or SKIN?

Which has more volatility & risk, YSG or SKIN?

Does the media prefer YSG or SKIN?

Summary

How does Beauty Health compare to Nu Skin Enterprises?

Which has stronger earnings & valuation, SKIN or NUS?

Does the media favor SKIN or NUS?

Which has more risk & volatility, SKIN or NUS?

Is SKIN or NUS more profitable?

Do institutionals and insiders have more ownership in SKIN or NUS?

Do analysts prefer SKIN or NUS?

Summary

How does Beauty Health compare to Nature's Sunshine Products?

Do institutionals & insiders believe in SKIN or NATR?

Which has more risk & volatility, SKIN or NATR?

Does the media refer more to SKIN or NATR?

Do analysts rate SKIN or NATR?

Is SKIN or NATR more profitable?

Which has higher earnings and valuation, SKIN or NATR?

Summary

How does Beauty Health compare to Niagen Bioscience?

Which has better valuation and earnings, SKIN or NAGE?

Which has more risk and volatility, SKIN or NAGE?

Do institutionals and insiders believe in SKIN or NAGE?

Do analysts rate SKIN or NAGE?

Does the media favor SKIN or NAGE?

Is SKIN or NAGE more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SKIN vs. The Competition

Beauty Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools